Investigating how caveolae help regulate eye pressure in glaucoma
Caveolae-Based Mechanosensors for Conventional Outflow Regulation
This study is looking at tiny structures in our cells that might help control eye pressure, which is important for people with glaucoma, and it aims to find out how certain gene variations could affect this pressure and lead to better ways to prevent or treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11035249 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of caveolae, small structures in cells, in regulating intraocular pressure (IOP), which is crucial for managing glaucoma, a leading cause of blindness. The study will explore how gene variants related to caveolae formation affect IOP and contribute to primary open angle glaucoma (POAG). By examining the mechanical responsiveness of the conventional outflow pathway in the eye, the researchers aim to uncover the cellular mechanisms that help maintain normal IOP levels. This could lead to new insights into how to prevent or treat glaucoma effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with primary open angle glaucoma or those at risk due to genetic factors affecting caveolae.
Not a fit: Patients with glaucoma caused by factors unrelated to caveolae or those with other types of glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better manage intraocular pressure and reduce the risk of blindness in glaucoma patients.
How similar studies have performed: While the specific focus on caveolae in this context is novel, previous research has shown that understanding cellular mechanisms in glaucoma can lead to significant advancements in treatment.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Elliott, Michael H — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Elliott, Michael H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.